20 Jun
Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits
Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women’s Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company. The partnership will include the promotion of FIRST® – Progesterone VGS, vaginal suppository compounding kits.
Beginning early July, 2011, Centrix Pharmaceutical sales representatives will promote FIRST® - Progesterone VGS compounding kits from CutisPharma, Inc. in physician offices, clinics, and hospitals who specialize in obstetrics and gynecology in addition to retail pharmacies nationwide.
Similar Posts:
- Banned HIV Test Kit Still Used in Kenya
- Sosei to introduce NorLevo oral emergency contraceptive in Japan
- Too many women get HPV tests, study says
- Common sense key when it comes to skin care
- Argentina Fines Drug Company Over Vaccine
Respond to this post